Inventor · disambiguated record
Jean-Francois Mayaux
Also filed as: MAYAUX JEAN-FRANCOIS · MAYAUX JEAN-FRANÇOIS
9 granted patents·2 pending applications·417 citations·filing 1986–2004
90Inventor score
Files withRHONE POULENC SANTE5GENETICA3AVENTIS PHARMA SA1RHONE POULENC CHIMIE1RHONE POULENC RORER SA1
Top patents by PatentIndex Score
11 records- 0190US6165470AAlbumin derivatives with therapeutic functionsRHONE POULENC SANTE·Filed 1998·Granted Dec 26, 2000·101 cites·15 claims
- 0287US5646012AYeast promoter and use thereofRHONE POULENC RORER SA·Filed 1995·Granted Jul 8, 1997·79 cites·23 claims
- 0387US5100784AProcess for the preparation of mature human serum albuminGENETICA·Filed 1987·Granted Mar 31, 1992·63 cites·6 claims
- 0484US4914027AProcess for the microbiological preparation of human serum albuminGENETICA·Filed 1986·Granted Apr 3, 1990·82 cites·4 claims
- 0582US5187261AProcess for the preparation of mature human serum albuminGENETICA·Filed 1991·Granted Feb 16, 1993·70 cites·4 claims
- 0660US2005048471A1Albumin derivatives with therapeutic functionsRHONE POULENC SANTE·Filed 2004·Application pending·0 cites
- 0753US5258292AEnzymic process for the synthesis of ammonium adipateRHONE POULENC CHIMIE·Filed 1991·Granted Nov 2, 1993·14 cites·6 claims
- 0853US2003054554A1Albumin derivatives with therapeutic functionsRHONE POULENC SANTE·Filed 2002·Application pending·0 cites
- 0950US5766918AEnantioselective amidases and uses thereofRHONE POULENC SANTE·Filed 1995·Granted Jun 16, 1998·7 cites·12 claims
- 1045USRE40940EYeast promoter and use thereofAVENTIS PHARMA SA·Filed 2001·Granted Oct 20, 2009·0 cites·23 claims
- 1131US5260208AEnantioselective amidases, DNA sequences encoding them, method of preparation and utilizationRHONE POULENC SANTE·Filed 1990·Granted Nov 9, 1993·1 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Jean-Francois Mayaux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →